Inthera
Edit

Inthera

https://intherabio.com/
Last activity: 08.11.2022
Tags:BioTechDesign
Inthera Bioscience is an emerging Swiss biotechnology company that develops innovative and highly effective therapies against currently incurable cancers. The company is tackling “undruggable” targets with innovative chemistry for the design of small molecule inhibitors of intracellular protein-protein interactions. The most advanced of these first-in-class therapeutics, a modulator of dysregulated transcription, is currently progressing towards clinical stage.
Mentions
6
Total raised: $16.382668M

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
26.06.2018Series A$5.475277M-startuptic...
31.05.2017Series A$10.907391...-finsmes.co...

Mentions in press and media 6

DateTitleDescriptionSource
26.06.2018Inthera Bioscience Raises €4.7M Second Tranche of €9.6M Seri...Inthera Bioscience AG, a Wädenswil, Switzerland-based pre-clinical stage oncology company targeting ...finsmes.co...
26.06.2018Inthera Bioscience secures €4.7 million in series A financin... Inthera Bioscience is a biopharmaceitical company developing first-in-class targeted small molecul...startuptic...
02.06.2017Inthera Bioscience Raises CHF 10.5 Million in Series A Finan... The financing round was led by Merck Ventures, with equal contribution from Aglaia BioMedical Vent...startuptic...
31.05.2017Inthera Bioscience Raises CHF10.5M in Series A Financing Rou...Inthera Bioscience, a Zurich, Switzerland-based biopharmaceutical company developing targeted small ...finsmes.co...
15.12.2015Inthera Bioscience Raises $3.7M in Seed FundingInthera Bioscience, a Zürich, Switzerland-based biopharmaceutical company focused on the development...finsmes.co...
14.12.2015Inthera Bioscience raises EUR 3.4 million in seed financing ... Inthera Bioscience is focused on developing inhibitors of intracellular protein-protein interactio...startuptic...